EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Corticosteroid treatment modulates immune cell populations in the glioblastoma microenvironment

Rune Just Clausen iD, Sofie Sorgenfri Hjerrild Nielsen, Julie Jacobsen iD, Line Viftrup Buchwald, Vilde Pedersen, Nadine Margaretha Hammouda iD, Nicolai Schou Bager, Kirsten Grunnet, Hans Skovgaard Poulsen, Simone Maarup, Benedikte Hasselbalch iD, Thomas Urup iD und 3 weitere

Neuro-Oncology Advances · 12.01.2026 · 8 (1)

DOI: 10.1093/noajnl/vdag258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 07.10.2026. Verfasst von Rune Just Clausen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Copenhagen University Hospital-Rigshospitalet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Corticosteroids play a crucial role in alleviating tumor-associated edema in patients with brain tumors. However, their impact on the tumor microenvironment within glioblastoma remains largely unexplored. In the context of increasing interest in immunotherapy and limited clinical progress for glioblastoma patients, it is important to understand how corticosteroid therapy influences the immune microenvironment.

Methods

This study involved 80 glioblastoma patients, 41 of whom received corticosteroids preoperatively and 39 who did not. The groups were balanced for key clinical prognostic parameters. Through immunohistochemical staining and image analysis-based software classifiers, we quantitatively assessed a broad marker panel covering immune, myeloid, hypoxia-related, and tumor-associated features of the glioblastoma microenvironment.

Results

Our analysis revealed a more than 2-fold decrease in FOXP3+ regulatory T cells in glioblastoma tissue samples from patients who received corticosteroids. In dose-subgroup analyses, high-dose corticosteroid exposure was associated with increased CD68+ and CD204+ myeloid/macrophage-marker abundance. CD8 and CD4 T cell counts, as well as CD86, TMEM119, HIF-1α, PD-L1, and SOX2, remained similar across all groups.

Conclusions

Our findings suggest that corticosteroid treatment is associated with selective changes in T cell and myeloid/macrophage-marker abundance within the tumor microenvironment. These findings highlight corticosteroid exposure as an important factor to consider when interpreting immune profiles and developing immune-based therapies in glioblastoma.

Schlagwörter

Stichwörter der Autor:innen

corticosteroidsdigital pathologyglioblastomaimmune microenvironmentprednisolone

Autor:innen und Institutionen

  • Department of Pathology, The Bartholin Institute, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Clinical Medicine and Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
  • DCCC Brain Tumor Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

ORCID-Profile: Rune Just Clausen, Julie Jacobsen, Nadine Margaretha Hammouda, Benedikte Hasselbalch, Thomas Urup, Signe Regner Michaelsen, Sara Blaabjerg Artzi, Bjarne Winther Kristensen

Förderung

  • Copenhagen University Hospital-Rigshospitalet

Zitieren

APA

Clausen, R. J., Nielsen, S. S. H., Jacobsen, J., Buchwald, L. V., Pedersen, V., Hammouda, N. M., Bager, N. S., Grunnet, K., Poulsen, H. S., Maarup, S., Hasselbalch, B., Urup, T., Michaelsen, S. R., Artzi, S. B., & Kristensen, B. W. (2026). Corticosteroid treatment modulates immune cell populations in the glioblastoma microenvironment. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag258

Vancouver

Clausen RJ, Nielsen SSH, Jacobsen J, Buchwald LV, Pedersen V, Hammouda NM, et al. Corticosteroid treatment modulates immune cell populations in the glioblastoma microenvironment. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag258

BibTeX
@article{Clausen2026,
  author = {Clausen, Rune Just and Nielsen, Sofie Sorgenfri Hjerrild and Jacobsen, Julie and Buchwald, Line Viftrup and Pedersen, Vilde and Hammouda, Nadine Margaretha and Bager, Nicolai Schou and Grunnet, Kirsten and Poulsen, Hans Skovgaard and Maarup, Simone and Hasselbalch, Benedikte and Urup, Thomas and Michaelsen, Signe Regner and Artzi, Sara Blaabjerg and Kristensen, Bjarne Winther},
  title = {Corticosteroid treatment modulates immune cell populations in the glioblastoma microenvironment},
  journal = {Neuro-Oncology Advances},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1093/noajnl/vdag258}
}
Kostenlos starten →